US Patent 9370507 Pyridonyl guanidine F
Patent 9370507 was granted and assigned to Lycera on June, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+257 characters)
Article
Patent abstract
The invention provides pyridonyl guanidine compounds that inhibit F1F0-ATPase, and methods of using pyridonyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Alexander R. Hurd0
Chad A. Van Huis0
Clarke B. Taylor0
Gary D. Glick0
Matthew N. Mattson0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09370507 Pyridonyl guanidine F US Patent 9370507 Pyridonyl guanidine F
Infobox
Patent Number
09370507
Patent Number
9370507
Edits on 5 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09370507 Pyridonyl guanidine F
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09370507
Date of patent
June 21, 2016
Patent application number
14675832
Date Filed
April 1, 2015
Patent primary examiner
Find more entities like US Patent 9370507 Pyridonyl guanidine F
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.